|
|||||
|
|
Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia |
|
| Authors: | Yood Marianne Ulcickas Oliveria Susan A Cziraky Mark Hirji Ishan Hamdan Muhammad Davis Catherine |
| Affiliation: | EpiSource, LLC, Newton, MA, USA. muyood@muyood.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |